{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:58:49Z","timestamp":1790002729697,"version":"4.0.1"},"reference-count":48,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100006484","name":"vifor pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p> The branches of the immune system work in concert to defend against pathogens and prevent tissue damage due to excessive inflammation. Uropathogens in general, and uropathogenic Escherichia coli (UPEC) in particular, have evolved a diverse range of virulence mechanisms to avoid detection and destruction by the mucosal immune system of the urinary tract. Research towards a vaccine active against UPEC continues but has yet to be successful. Orally administered immunomodulatory bacterial lysates both stimulate and modulate the immune response in the urinary tract via the integrated mucosal immune system. The 2018 European Association of Urology (EAU) guidelines on treating acute uncomplicated cystitis recommend aiming for rapid resolution of symptoms, reduction of morbidity, and prophylaxis against reinfection. Recommended short-term antibiotic therapy has the advantage of good compliance, low cost, few adverse events, and low impact on bacterial flora. Antibiotic treatment of asymptomatic bacteriuria is only indicated during pregnancy and before invasive interventions. For recurrent infection, prophylaxis using behavioral modification and counseling should be employed first, then nonantibiotic prophylaxis, and, finally, low-dose continuous or postcoital antibiotic prophylaxis. The 2018 EAU guidelines give a strong recommendation for the oral bacterial lysate immunomodulator OM-89. All other nonantibiotic prophylactic strategies require more data, except for topical estrogen for postmenopausal women. For last-resort antibiotic prophylaxis, nitrofurantoin or fosfomycin trometamol are recommended. Guidelines for Latin America are currently being drafted, taking into account the unique ethnicity, availability of medicines, prevalence of antibiotic resistance, and healthcare practices found throughout the region. <\/jats:p>","DOI":"10.1177\/1756287218824089","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T12:51:06Z","timestamp":1556801466000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevention of recurrent urinary tract infections: bridging the gap                     between clinical practice and guidelines in Latin America"],"prefix":"10.1177","volume":"11","author":[{"given":"Jos\u00e9 Antonio","family":"Ortega Martell","sequence":"first","affiliation":[{"name":"Universidad Aut\u00f3noma del Estado de\r                        Hidalgo, Carr. Pachuca - Actopan, Campo de Tiro, 42039, Pachuca de Soto,\r                        Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt G.","family":"Naber","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen,\r                        Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Milhem Haddad","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, S\u00e3o\r                        Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Tir\u00e1n Saucedo","sequence":"additional","affiliation":[{"name":"Instituto Mexicano de Infectolog\u00eda,\r                        Ginecolog\u00eda y Obstetricia, Universidad de Monterrey, Monterrey,\r                        Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Alfonso","family":"Dom\u00ednguez Burgos","sequence":"additional","affiliation":[{"name":"Instituto Mexicano de Infectolog\u00eda,\r                        Ginecolog\u00eda y Obstetricia, Universidad de Monterrey, Monterrey,\r                        Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"bibr1-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-015-0581-6"},{"key":"bibr2-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432"},{"key":"bibr3-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1038\/nri3887"},{"key":"bibr4-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.36"},{"key":"bibr5-1756287218824089","first-page":"2662","volume":"198","author":"Floyd KA","year":"2016","journal-title":"Escherichia coli. J Bacteriol"},{"key":"bibr6-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1007\/s11884-016-0345-8"},{"key":"bibr7-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03968-5"},{"key":"bibr8-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1038\/nri3523"},{"key":"bibr9-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.08.011"},{"key":"bibr10-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-005-0046-y"},{"key":"bibr11-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1159\/000189674"},{"key":"bibr12-1756287218824089","unstructured":"Bonkat G, Pickard R, Bartoletti R, et                             al. EAU Guidelines. Edn. presented at the EAU Annual                         Congress Copenhagen 2018. ISBN 978-94-92671-01-1, EAU Guidelines                     Office, Arnhem, The Netherlands, http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/"},{"key":"bibr13-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1159\/000486138"},{"key":"bibr14-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03946-14"},{"key":"bibr15-1756287218824089","unstructured":"US Food and Drug Administration. FDA approves\n                        safety labeling changes for fluoroquinolones, https:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm500325.htm\n                        (2016, accessed 26 July\n                    2016)."},{"key":"bibr16-1756287218824089","unstructured":"Auwaerter PG. Fluoroquinolones not first line: FDA advisory                         reinforces standard practice in ambulatory care, https:\/\/www.medscape.com\/viewarticle\/863778?nlid=105987_1842src=WNL_mdplsfeat_160607_mscpedit_wiruac=143664DGspon=17impID=1120486faf=1                         (2016, accessed 2 June                     2016)."},{"key":"bibr17-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8383"},{"key":"bibr18-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis541"},{"key":"bibr19-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021042"},{"key":"bibr20-1756287218824089","first-page":"1655","volume":"61","author":"Cai T","year":"2015","journal-title":"Clin Infect Dis"},{"key":"bibr21-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.024"},{"key":"bibr22-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198208193070802"},{"key":"bibr23-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302186"},{"key":"bibr24-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1159\/000356177"},{"key":"bibr25-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6544"},{"key":"bibr26-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01054-9"},{"key":"bibr27-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060280"},{"key":"bibr28-1756287218824089","first-page":"9","volume":"65","author":"Wagenlehner FM","year":"2013","journal-title":"Minerva Urol Nefrol"},{"key":"bibr29-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608153350703"},{"key":"bibr30-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309093291102"},{"key":"bibr31-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir183"},{"key":"bibr32-1756287218824089","first-page":"Cd001321","volume":"10","author":"Jepson RG","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr33-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1091-6"},{"key":"bibr34-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35648-3"},{"key":"bibr35-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.12.009"},{"key":"bibr36-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.04.142"},{"key":"bibr37-1756287218824089","first-page":"25","volume":"19","author":"Baertschi R","year":"2003","journal-title":"Int J Immunother"},{"key":"bibr38-1756287218824089","first-page":"195","volume":"44","author":"Czerwionka-Szaflarska M","year":"1996","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"bibr39-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(96)80055-5"},{"key":"bibr40-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40084-X"},{"key":"bibr41-1756287218824089","first-page":"713","volume":"138","author":"Popa GLK","year":"1996","journal-title":"Muenchener Medizinische Wochenschrif"},{"key":"bibr42-1756287218824089","author":"Tavares W","year":"2011","journal-title":"Diretrizes Cl\u00ednicas na Sa\u00fade"},{"key":"bibr43-1756287218824089","first-page":"S437","volume":"78","author":"Del Pilar Velazquez M","year":"2010","journal-title":"Ginecol Obstet Mex"},{"key":"bibr44-1756287218824089","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh2016884100-104"},{"key":"bibr45-1756287218824089","doi-asserted-by":"publisher","DOI":"10.14777\/uti.2017.12.1.7"},{"key":"bibr46-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.05.010"},{"key":"bibr47-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1571252"},{"key":"bibr48-1756287218824089","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1585074"}],"updated-by":[{"DOI":"10.1177\/1756287219863170","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000}}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756287218824089","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1756287218824089","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756287218824089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T09:54:48Z","timestamp":1738058088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1756287218824089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":48,"alternative-id":["10.1177\/1756287218824089"],"URL":"https:\/\/doi.org\/10.1177\/1756287218824089","relation":{"correction":[{"id-type":"doi","id":"10.1177\/1756287219863170","asserted-by":"object"}]},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"value":"1756-2872","type":"print"},{"value":"1756-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"article-number":"1756287218824089"}}